Bogart Wealth LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$955 Hold
6
﹤0.01% 1626
2026
Q1
$770 Hold
6
﹤0.01% 1501
2025
Q4
$735 Hold
6
﹤0.01% 1376
2025
Q3
$602 Hold
6
﹤0.01% 1366
2025
Q2
$498 Hold
6
﹤0.01% 1353
2025
Q1
$487 Buy
+6
New +$536 ﹤0.01% 1288
2024
Q2
Sell
-843
Closed -$80K 1180
2024
Q1
$80K Hold
843
﹤0.01% 305
2023
Q4
$75.3K Hold
843
﹤0.01% 305
2023
Q3
$61.6K Hold
843
﹤0.01% 314
2023
Q2
$70.1K Hold
843
﹤0.01% 288
2023
Q1
$64.2K Hold
843
﹤0.01% 286
2022
Q4
$70K Sell
843
-35
-4% -$2.83K ﹤0.01% 265
2022
Q3
$70K Buy
878
+35
+4% +$2.95K 0.01% 258
2022
Q2
$63K Hold
843
0.01% 259
2022
Q1
$76K Hold
843
0.01% 234
2021
Q4
$94K Hold
843
0.01% 208
2021
Q3
$106K Hold
843
0.01% 182
2021
Q2
$114K Sell
843
-114
-12% -$15K 0.01% 171
2021
Q1
$130K Buy
957
+759
+383% +$114K 0.02% 154
2020
Q4
$27K Buy
+198
New +$25.4K 0.01% 248

Other funds holding XBI

Bogart Wealth LLC's XBI Position: Q2 2026 in Review

Bogart Wealth LLC held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 6 shares worth $955. The position accounts for ﹤0.01% of the portfolio, ranked #1626.

Bogart Wealth LLC first reported a position in XBI in Q4 2020 and has held it in 20 quarters since. The position peaked at $130K in Q1 2021. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Bogart Wealth LLC held 6 shares of State Street SPDR S&P Biotech ETF worth $955 as of Q2 2026.
  • Bogart Wealth LLC left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1626 holding.
  • Bogart Wealth LLC first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 20 quarters since.
  • Bogart Wealth LLC's State Street SPDR S&P Biotech ETF position peaked at $130K in Q1 2021.
  • 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.